Assignment Prompt & Instructions
See attached
– ## POWERPOINTPRESENTATIONINSTRUCTION.docx
– ## JohnsonandJohnsonVisionandMissionInfoPP1.docx
– ## Swotpahse2PP.pdf
– JohnsonJohnson5YearProjection..docx
**## POWERPOINTPRESENTATIONINSTRUCTION.docx**
Put data into a Power Point presentation. Phase 1, 2 and 3. Please Cite references and put in APA Format.
**## JohnsonandJohnsonVisionandMissionInfoPP1.docx**
**Johnson & Johnson Vision and Mission Statement**
**Vision and Mission Statement for Johnson and Johnson and Assessment**
**Mission Statement** _“Bringing science and sense of sight to life through world-class innovation and customer experience.”_
**Vision Statement** _“To help people see better, connect better, live better.”_
**Assessment of Mission and Vision Statements**
The mission statement of Johnson & Johnson incorporates a potent combination of innovation and human-friendly design. Underlining its mission statement of making science and sense of sight come to life, the firm underscores its dedication to utilizing the latest innovation in the field of ophthalmology and optics to address real health issues faced by the world today (Johnson, 2025). The term world-class innovation touches upon the technological and product development competitive advantage of J&J, whereas a customer experience validates the patient-based philosophy of J&J. This mission demonstrates a high compatibility with the corporate values of the bigger firm of Johnson & Johnson wherein the scientific progress is mixed with humane caring (Johnson, 2025). In general, the mission is precise, goal-oriented, and sector-wide, effectively demonstrating the strategic focus of the company as it concerns high-quality eye care solutions capable of enhancing health outcomes and user satisfaction among people of various groups.
The vision statement, gives the brief and heartfelt message connecting the topic of eye health with the overall quality of life. The concept of see better is a clear candidate to highlight the fundamental functional outcome of what J&J Vision sells, but the term connect better and live better extend the commodity to indicate how vision influences emotional, social and business wellbeing (Johnson, 2025). It encompasses a comprehensive view of health, not just clinical outcomes, to encompass relationships and human relationship and quality of life. This strategic vision makes Johnson & Johnson Vision not only a supplier of products, but as something that adds life to it. Although short, the vision can be formulated more precisely on technological leadership or long-term sustainability ambitions to enhance strategy.
Reference:
Johnson, K. (2025, March 13).
_Johnson & Johnson Mission Statement: Vision: Core values._ Business Strategy Hub.
[https://bstrategyhub.com/johnson-johnson-mission-statement-vision-core-values-analysis/](https://bstrategyhub.com/johnson-johnson-mission-statement-vision-core-values-analysis/)
**## Swotpahse2PP.pdf**
1
SWOT Matrix for Johnson & Johnson
Strategic Implications
The market leadership of Johnson & Johnson includes its key strengths, including
strong global brand, the presence of differentiated products, and commitment into innovation
as a result of its on-going R&D (Pereira, 2024) \. All these attributes enable Johnson &
Johnson to sustain and expand its competitive advantage. With the help of these advantages,
J&J can actively go after innovation in other hotspots such as biologics, digital health, and
targeted therapeutics. Through its CSR and international presence, it is able to establish brand
loyalty, especially in underserved markets, which not only strengthens its profitability, but
also builds up levels of brand credibility (David et al., 2023). Johnson & Johnson can achieve
this by furthering investments in international collaborations and sustaining a strong talent
pool to keep pace with the new trends of the markets, enhance the agility of operations, and
enhance its role as a global health solutions leader.
Nevertheless, other weaknesses like product recall, liability, and a slow product
innovation cycle are the major internal threats to its continued development (Pereira, 2024).
Such difficulties may undermine the consumer confidence, reduce efficiency, and may end up
causing losses. J&J has to shift its organizational structure and minimise bureaucratic inertia
to lessen product development time and invest in fast-moving R&D in order to shorten scales
of time (David et al., 2023). It can take action to prevent legal weaknesses by enhancing
quality control measures and risk management structure to defend its brand integrity. Making
internal transformation a primary goal will assist the company in avoiding problems related
to the efficiency of operations and reinforce the capacity of the company to react to
disruption of the industry and shifting consumer demands as fast as possible.
On the external front, the risk is mainly economic volatility, regulatory pressure, and
increasing competition, particularly on the pharmaceutical and MedTech market. The firm
has to expand into green innovation and acquire in areas of high potential through
acquisitions as a strategy to seize the opportunities (Pereira, 2024). Remaining responsive to
the global health trends and adhering to sustainable business practices, J&J will be able to
win over eco-friendly consumers and investor demands that are less lenient toward poor ESG
performances (David et al., 2023). Also, digital adoption and use of information on customer
engagement will play a pivotal role in handling social media risks and their behavioral
2
change. The ability to align these initiatives to its pipeline of innovation and CSR mission
will enable J&J remain a global leader and future-proof its operations.
Johnson & Johnson SWOT Matrix
Key Strengths Critical Weaknesses
1. Diverse global product
portfolio. (Pharma,
MedTech, Consumer
Health).
1. Litigation risks and legal
challenges.
2. Strong brand equity and
global reputation.
2. Product recalls and
quality concerns.
3. Advanced R&D
capabilities and
innovation.
3. Slow innovation cycles
and R&D lag.
4. Strong CSR and global
supply chain.
4. Complex and
bureaucratic organizational
structure.
Market Opportunities SO, Actions WO Actions
1. Expansion of pharmaceutical
innovations and strategic market
acquisitions.
Use J&J’s R&D to lead in
digital therapeutics and
precision health.
Partner with startups to
speed R&D and overcome
delays.
2. Global health initiatives and
partnerships.
Leverage brand and CSR
to grow in underserved
regions.
Streamline post-acquisition
integration for global
expansion.
3. Sustainable and eco-friendly
product innovation.
Innovate green medical
devices and personal care
through advanced labs.
Improve QA systems to
reduce recalls in eco-
product lines.
4. Growth in targeted therapeutics
and digital health.
Acquire biotech firms to
enhance specialized
product pipelines.
Collaborate externally to
mitigate innovation risks
and diversify offerings.
Market Threats ST Actions WT Actions
1. Intense global competition. Diversify product lines to
reduce exposure to high-
risk segments.
Flatten internal structure to
reduce delays in crisis
management.
2. Regulatory scrutiny and
compliance burden.
Strengthen compliance
teams to meet global
regulations efficiently.
Launch risk-monitoring and
early-warning systems.
3. Supply chain disruptions and
manufacturing risks.
Build resilient, digitized
supply networks across
core markets.
Expand compliance training
and regulatory audits.
4. Rising legal and public relations
risks.
Enhance transparency and
PR response to protect
brand reputation.
Create a specialized unit for
social media and litigation
response.
3
Translating Actions to Strategic Recommendations
SO, and WO Strategy
The market leadership of Johnson & Johnson includes its key strengths, including
strong global brand, the presence of differentiated products, and commitment into innovation
as a result of its on-going R&D (Pereira, 2024). All these attributes enable Johnson &
Johnson to sustain and expand its competitive advantage. Johnson & Johnson has an
opportunity to develop its pharmaceutical and digital health innovation with its robust
research and development and brand reputation. The company needs to make an investment
in AI-based diagnostics and therapeutics with the help of SO strategies, considering young
adults and geriatric populations (Lehoux et al., 2022). At the same time, it must come up with
sustainable, eco-friendly health products that resonate with its CSR objectives (Lehoux et al.,
2022). Regarding the WO aspect of the business, Johnson & Johnson has to mitigate
ineffective R&D turnaround by partnering with nimble biotechnology startups in innovation.
The reinforcement of its internal structure to achieve a better internal integration will allow it
to acquire organizations more quickly and adapt to world health opportunities. These
strategies are in line with the mission of the firm to innovate with heart and science towards a
healthier world.
ST Strategy
In a bid to combat the rising global competition and regulatory pressure, Johnson &
Johnson can capitalize on the following strengths namely global reach, CSR leadership as
well as developed R&D. Another important ST approach is to create a stronger supply chain
with the help of digital forecasting tools, particularly following COVID-19 related
disruptions. Moreover, by actively engaging with regulators and making its information on
drug efficacy and safety easily accessible to everyone, the company can defend its image as
well (David et al., 2017). Combination with scientific integrity will contribute to the
4
maintenance of consumer trust, which can be strengthened with transparency. Such plans
align with the company mission of Johnson & Johnson, which commands attention to quality,
integrity and safety as inherent in its Credo of living in response to global pressures.
WT Strategy
The ability to reduce internal vulnerabilities and to prevent external risks will
necessitate Johnson & Johnson to strengthen its risk management system. The WT strategies
ought to factor in reorganization endeavors towards lessening bureaucracy and improved
monitoring of the legal and regulatory environments (David et al., 2017). Moreover, there
should be crisis management and PR teams that would address the cases of public
controversy and risk on social media as quickly as possible (David et al., 2017). Internal
quality checks and adherence training will avert further product recall and regulatory fines.
These defensive strategies are necessary to eliminate doubt on the long-term confidence of
stakeholders in Johnson & Johnson and restore the position of the company as the leader in
ethical, safe, and responsible healthcare innovations.
References
David, F. R., David, F. R., & David, M. E. (2017). Strategic management: concepts and
cases: A competitive advantage approach (Vol. 127). New Jersey: Pearson.
Lehoux, P., Silva, H. P., Rocha de Oliveira, R., Sabio, R. P., & Malas, K. (2022).
Responsible innovation in health and health system sustainability: insights from
health innovators’ views and practices. Health Services Management Research, 35(4),
196-205.
Pereira, D. (2024, December 26). Johnson & Johnson Swot Analysis (2025). Business Model
Analyst. https://businessmodelanalyst.com/johnson-johnson-swot-
analysis/?srsltid=AfmBOor8GBml0pt4t4M4ZQmuPey4VbO01HTmr4KhYw-
W4q_z_pgJJR14
5
**JohnsonJohnson5YearProjection..docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/johnsonjohnson5yearprojection-docx)
**JohnsonJohnson5YearProjection..docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/johnsonjohnson5yearprojection-docx)
**## POWERPOINTPRESENTATIONINSTRUCTION.docx**
Put data into a Power Point presentation. Phase 1, 2 and 3. Please Cite references and put in APA Format.
**## JohnsonandJohnsonVisionandMissionInfoPP1.docx**
**Johnson & Johnson Vision and Mission Statement**
**Vision and Mission Statement for Johnson and Johnson and Assessment**
**Mission Statement** _“Bringing science and sense of sight to life through world-class innovation and customer experience.”_
**Vision Statement** _“To help people see better, connect better, live better.”_
**Assessment of Mission and Vision Statements**
The mission statement of Johnson & Johnson incorporates a potent combination of innovation and human-friendly design. Underlining its mission statement of making science and sense of sight come to life, the firm underscores its dedication to utilizing the latest innovation in the field of ophthalmology and optics to address real health issues faced by the world today (Johnson, 2025). The term world-class innovation touches upon the technological and product development competitive advantage of J&J, whereas a customer experience validates the patient-based philosophy of J&J. This mission demonstrates a high compatibility with the corporate values of the bigger firm of Johnson & Johnson wherein the scientific progress is mixed with humane caring (Johnson, 2025). In general, the mission is precise, goal-oriented, and sector-wide, effectively demonstrating the strategic focus of the company as it concerns high-quality eye care solutions capable of enhancing health outcomes and user satisfaction among people of various groups.
The vision statement, gives the brief and heartfelt message connecting the topic of eye health with the overall quality of life. The concept of see better is a clear candidate to highlight the fundamental functional outcome of what J&J Vision sells, but the term connect better and live better extend the commodity to indicate how vision influences emotional, social and business wellbeing (Johnson, 2025). It encompasses a comprehensive view of health, not just clinical outcomes, to encompass relationships and human relationship and quality of life. This strategic vision makes Johnson & Johnson Vision not only a supplier of products, but as something that adds life to it. Although short, the vision can be formulated more precisely on technological leadership or long-term sustainability ambitions to enhance strategy.
Reference:
Johnson, K. (2025, March 13).
_Johnson & Johnson Mission Statement: Vision: Core values._ Business Strategy Hub.
[https://bstrategyhub.com/johnson-johnson-mission-statement-vision-core-values-analysis/](https://bstrategyhub.com/johnson-johnson-mission-statement-vision-core-values-analysis/)
**## Swotpahse2PP.pdf**
1
SWOT Matrix for Johnson & Johnson
Strategic Implications
The market leadership of Johnson & Johnson includes its key strengths, including
strong global brand, the presence of differentiated products, and commitment into innovation
as a result of its on-going R&D (Pereira, 2024) \. All these attributes enable Johnson &
Johnson to sustain and expand its competitive advantage. With the help of these advantages,
J&J can actively go after innovation in other hotspots such as biologics, digital health, and
targeted therapeutics. Through its CSR and international presence, it is able to establish brand
loyalty, especially in underserved markets, which not only strengthens its profitability, but
also builds up levels of brand credibility (David et al., 2023). Johnson & Johnson can achieve
this by furthering investments in international collaborations and sustaining a strong talent
pool to keep pace with the new trends of the markets, enhance the agility of operations, and
enhance its role as a global health solutions leader.
Nevertheless, other weaknesses like product recall, liability, and a slow product
innovation cycle are the major internal threats to its continued development (Pereira, 2024).
Such difficulties may undermine the consumer confidence, reduce efficiency, and may end up
causing losses. J&J has to shift its organizational structure and minimise bureaucratic inertia
to lessen product development time and invest in fast-moving R&D in order to shorten scales
of time (David et al., 2023). It can take action to prevent legal weaknesses by enhancing
quality control measures and risk management structure to defend its brand integrity. Making
internal transformation a primary goal will assist the company in avoiding problems related
to the efficiency of operations and reinforce the capacity of the company to react to
disruption of the industry and shifting consumer demands as fast as possible.
On the external front, the risk is mainly economic volatility, regulatory pressure, and
increasing competition, particularly on the pharmaceutical and MedTech market. The firm
has to expand into green innovation and acquire in areas of high potential through
acquisitions as a strategy to seize the opportunities (Pereira, 2024). Remaining responsive to
the global health trends and adhering to sustainable business practices, J&J will be able to
win over eco-friendly consumers and investor demands that are less lenient toward poor ESG
performances (David et al., 2023). Also, digital adoption and use of information on customer
engagement will play a pivotal role in handling social media risks and their behavioral
2
change. The ability to align these initiatives to its pipeline of innovation and CSR mission
will enable J&J remain a global leader and future-proof its operations.
Johnson & Johnson SWOT Matrix
Key Strengths Critical Weaknesses
1. Diverse global product
portfolio. (Pharma,
MedTech, Consumer
Health).
1. Litigation risks and legal
challenges.
2. Strong brand equity and
global reputation.
2. Product recalls and
quality concerns.
3. Advanced R&D
capabilities and
innovation.
3. Slow innovation cycles
and R&D lag.
4. Strong CSR and global
supply chain.
4. Complex and
bureaucratic organizational
structure.
Market Opportunities SO, Actions WO Actions
1. Expansion of pharmaceutical
innovations and strategic market
acquisitions.
Use J&J’s R&D to lead in
digital therapeutics and
precision health.
Partner with startups to
speed R&D and overcome
delays.
2. Global health initiatives and
partnerships.
Leverage brand and CSR
to grow in underserved
regions.
Streamline post-acquisition
integration for global
expansion.
3. Sustainable and eco-friendly
product innovation.
Innovate green medical
devices and personal care
through advanced labs.
Improve QA systems to
reduce recalls in eco-
product lines.
4. Growth in targeted therapeutics
and digital health.
Acquire biotech firms to
enhance specialized
product pipelines.
Collaborate externally to
mitigate innovation risks
and diversify offerings.
Market Threats ST Actions WT Actions
1. Intense global competition. Diversify product lines to
reduce exposure to high-
risk segments.
Flatten internal structure to
reduce delays in crisis
management.
2. Regulatory scrutiny and
compliance burden.
Strengthen compliance
teams to meet global
regulations efficiently.
Launch risk-monitoring and
early-warning systems.
3. Supply chain disruptions and
manufacturing risks.
Build resilient, digitized
supply networks across
core markets.
Expand compliance training
and regulatory audits.
4. Rising legal and public relations
risks.
Enhance transparency and
PR response to protect
brand reputation.
Create a specialized unit for
social media and litigation
response.
3
Translating Actions to Strategic Recommendations
SO, and WO Strategy
The market leadership of Johnson & Johnson includes its key strengths, including
strong global brand, the presence of differentiated products, and commitment into innovation
as a result of its on-going R&D (Pereira, 2024). All these attributes enable Johnson &
Johnson to sustain and expand its competitive advantage. Johnson & Johnson has an
opportunity to develop its pharmaceutical and digital health innovation with its robust
research and development and brand reputation. The company needs to make an investment
in AI-based diagnostics and therapeutics with the help of SO strategies, considering young
adults and geriatric populations (Lehoux et al., 2022). At the same time, it must come up with
sustainable, eco-friendly health products that resonate with its CSR objectives (Lehoux et al.,
2022). Regarding the WO aspect of the business, Johnson & Johnson has to mitigate
ineffective R&D turnaround by partnering with nimble biotechnology startups in innovation.
The reinforcement of its internal structure to achieve a better internal integration will allow it
to acquire organizations more quickly and adapt to world health opportunities. These
strategies are in line with the mission of the firm to innovate with heart and science towards a
healthier world.
ST Strategy
In a bid to combat the rising global competition and regulatory pressure, Johnson &
Johnson can capitalize on the following strengths namely global reach, CSR leadership as
well as developed R&D. Another important ST approach is to create a stronger supply chain
with the help of digital forecasting tools, particularly following COVID-19 related
disruptions. Moreover, by actively engaging with regulators and making its information on
drug efficacy and safety easily accessible to everyone, the company can defend its image as
well (David et al., 2017). Combination with scientific integrity will contribute to the
4
maintenance of consumer trust, which can be strengthened with transparency. Such plans
align with the company mission of Johnson & Johnson, which commands attention to quality,
integrity and safety as inherent in its Credo of living in response to global pressures.
WT Strategy
The ability to reduce internal vulnerabilities and to prevent external risks will
necessitate Johnson & Johnson to strengthen its risk management system. The WT strategies
ought to factor in reorganization endeavors towards lessening bureaucracy and improved
monitoring of the legal and regulatory environments (David et al., 2017). Moreover, there
should be crisis management and PR teams that would address the cases of public
controversy and risk on social media as quickly as possible (David et al., 2017). Internal
quality checks and adherence training will avert further product recall and regulatory fines.
These defensive strategies are necessary to eliminate doubt on the long-term confidence of
stakeholders in Johnson & Johnson and restore the position of the company as the leader in
ethical, safe, and responsible healthcare innovations.
References
David, F. R., David, F. R., & David, M. E. (2017). Strategic management: concepts and
cases: A competitive advantage approach (Vol. 127). New Jersey: Pearson.
Lehoux, P., Silva, H. P., Rocha de Oliveira, R., Sabio, R. P., & Malas, K. (2022).
Responsible innovation in health and health system sustainability: insights from
health innovators’ views and practices. Health Services Management Research, 35(4),
196-205.
Pereira, D. (2024, December 26). Johnson & Johnson Swot Analysis (2025). Business Model
Analyst. https://businessmodelanalyst.com/johnson-johnson-swot-
analysis/?srsltid=AfmBOor8GBml0pt4t4M4ZQmuPey4VbO01HTmr4KhYw-
W4q_z_pgJJR14
5
**JohnsonJohnson5YearProjection..docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/johnsonjohnson5yearprojection-docx)
**## POWERPOINTPRESENTATIONINSTRUCTION.docx**
Put data into a Power Point presentation. Phase 1, 2 and 3. Please Cite references and put in APA Format.
**## JohnsonandJohnsonVisionandMissionInfoPP1.docx**
**Johnson & Johnson Vision and Mission Statement**
**Vision and Mission Statement for Johnson and Johnson and Assessment**
**Mission Statement** _“Bringing science and sense of sight to life through world-class innovation and customer experience.”_
**Vision Statement** _“To help people see better, connect better, live better.”_
**Assessment of Mission and Vision Statements**
The mission statement of Johnson & Johnson incorporates a potent combination of innovation and human-friendly design. Underlining its mission statement of making science and sense of sight come to life, the firm underscores its dedication to utilizing the latest innovation in the field of ophthalmology and optics to address real health issues faced by the world today (Johnson, 2025). The term world-class innovation touches upon the technological and product development competitive advantage of J&J, whereas a customer experience validates the patient-based philosophy of J&J. This mission demonstrates a high compatibility with the corporate values of the bigger firm of Johnson & Johnson wherein the scientific progress is mixed with humane caring (Johnson, 2025). In general, the mission is precise, goal-oriented, and sector-wide, effectively demonstrating the strategic focus of the company as it concerns high-quality eye care solutions capable of enhancing health outcomes and user satisfaction among people of various groups.
The vision statement, gives the brief and heartfelt message connecting the topic of eye health with the overall quality of life. The concept of see better is a clear candidate to highlight the fundamental functional outcome of what J&J Vision sells, but the term connect better and live better extend the commodity to indicate how vision influences emotional, social and business wellbeing (Johnson, 2025). It encompasses a comprehensive view of health, not just clinical outcomes, to encompass relationships and human relationship and quality of life. This strategic vision makes Johnson & Johnson Vision not only a supplier of products, but as something that adds life to it. Although short, the vision can be formulated more precisely on technological leadership or long-term sustainability ambitions to enhance strategy.
Reference:
Johnson, K. (2025, March 13).
_Johnson & Johnson Mission Statement: Vision: Core values._ Business Strategy Hub.
[https://bstrategyhub.com/johnson-johnson-mission-statement-vision-core-values-analysis/](https://bstrategyhub.com/johnson-johnson-mission-statement-vision-core-values-analysis/)
**## Swotpahse2PP.pdf**
1
SWOT Matrix for Johnson & Johnson
Strategic Implications
The market leadership of Johnson & Johnson includes its key strengths, including
strong global brand, the presence of differentiated products, and commitment into innovation
as a result of its on-going R&D (Pereira, 2024) \. All these attributes enable Johnson &
Johnson to sustain and expand its competitive advantage. With the help of these advantages,
J&J can actively go after innovation in other hotspots such as biologics, digital health, and
targeted therapeutics. Through its CSR and international presence, it is able to establish brand
loyalty, especially in underserved markets, which not only strengthens its profitability, but
also builds up levels of brand credibility (David et al., 2023). Johnson & Johnson can achieve
this by furthering investments in international collaborations and sustaining a strong talent
pool to keep pace with the new trends of the markets, enhance the agility of operations, and
enhance its role as a global health solutions leader.
Nevertheless, other weaknesses like product recall, liability, and a slow product
innovation cycle are the major internal threats to its continued development (Pereira, 2024).
Such difficulties may undermine the consumer confidence, reduce efficiency, and may end up
causing losses. J&J has to shift its organizational structure and minimise bureaucratic inertia
to lessen product development time and invest in fast-moving R&D in order to shorten scales
of time (David et al., 2023). It can take action to prevent legal weaknesses by enhancing
quality control measures and risk management structure to defend its brand integrity. Making
internal transformation a primary goal will assist the company in avoiding problems related
to the efficiency of operations and reinforce the capacity of the company to react to
disruption of the industry and shifting consumer demands as fast as possible.
On the external front, the risk is mainly economic volatility, regulatory pressure, and
increasing competition, particularly on the pharmaceutical and MedTech market. The firm
has to expand into green innovation and acquire in areas of high potential through
acquisitions as a strategy to seize the opportunities (Pereira, 2024). Remaining responsive to
the global health trends and adhering to sustainable business practices, J&J will be able to
win over eco-friendly consumers and investor demands that are less lenient toward poor ESG
performances (David et al., 2023). Also, digital adoption and use of information on customer
engagement will play a pivotal role in handling social media risks and their behavioral
2
change. The ability to align these initiatives to its pipeline of innovation and CSR mission
will enable J&J remain a global leader and future-proof its operations.
Johnson & Johnson SWOT Matrix
Key Strengths Critical Weaknesses
1. Diverse global product
portfolio. (Pharma,
MedTech, Consumer
Health).
1. Litigation risks and legal
challenges.
2. Strong brand equity and
global reputation.
2. Product recalls and
quality concerns.
3. Advanced R&D
capabilities and
innovation.
3. Slow innovation cycles
and R&D lag.
4. Strong CSR and global
supply chain.
4. Complex and
bureaucratic organizational
structure.
Market Opportunities SO, Actions WO Actions
1. Expansion of pharmaceutical
innovations and strategic market
acquisitions.
Use J&J’s R&D to lead in
digital therapeutics and
precision health.
Partner with startups to
speed R&D and overcome
delays.
2. Global health initiatives and
partnerships.
Leverage brand and CSR
to grow in underserved
regions.
Streamline post-acquisition
integration for global
expansion.
3. Sustainable and eco-friendly
product innovation.
Innovate green medical
devices and personal care
through advanced labs.
Improve QA systems to
reduce recalls in eco-
product lines.
4. Growth in targeted therapeutics
and digital health.
Acquire biotech firms to
enhance specialized
product pipelines.
Collaborate externally to
mitigate innovation risks
and diversify offerings.
Market Threats ST Actions WT Actions
1. Intense global competition. Diversify product lines to
reduce exposure to high-
risk segments.
Flatten internal structure to
reduce delays in crisis
management.
2. Regulatory scrutiny and
compliance burden.
Strengthen compliance
teams to meet global
regulations efficiently.
Launch risk-monitoring and
early-warning systems.
3. Supply chain disruptions and
manufacturing risks.
Build resilient, digitized
supply networks across
core markets.
Expand compliance training
and regulatory audits.
4. Rising legal and public relations
risks.
Enhance transparency and
PR response to protect
brand reputation.
Create a specialized unit for
social media and litigation
response.
3
Translating Actions to Strategic Recommendations
SO, and WO Strategy
The market leadership of Johnson & Johnson includes its key strengths, including
strong global brand, the presence of differentiated products, and commitment into innovation
as a result of its on-going R&D (Pereira, 2024). All these attributes enable Johnson &
Johnson to sustain and expand its competitive advantage. Johnson & Johnson has an
opportunity to develop its pharmaceutical and digital health innovation with its robust
research and development and brand reputation. The company needs to make an investment
in AI-based diagnostics and therapeutics with the help of SO strategies, considering young
adults and geriatric populations (Lehoux et al., 2022). At the same time, it must come up with
sustainable, eco-friendly health products that resonate with its CSR objectives (Lehoux et al.,
2022). Regarding the WO aspect of the business, Johnson & Johnson has to mitigate
ineffective R&D turnaround by partnering with nimble biotechnology startups in innovation.
The reinforcement of its internal structure to achieve a better internal integration will allow it
to acquire organizations more quickly and adapt to world health opportunities. These
strategies are in line with the mission of the firm to innovate with heart and science towards a
healthier world.
ST Strategy
In a bid to combat the rising global competition and regulatory pressure, Johnson &
Johnson can capitalize on the following strengths namely global reach, CSR leadership as
well as developed R&D. Another important ST approach is to create a stronger supply chain
with the help of digital forecasting tools, particularly following COVID-19 related
disruptions. Moreover, by actively engaging with regulators and making its information on
drug efficacy and safety easily accessible to everyone, the company can defend its image as
well (David et al., 2017). Combination with scientific integrity will contribute to the
4
maintenance of consumer trust, which can be strengthened with transparency. Such plans
align with the company mission of Johnson & Johnson, which commands attention to quality,
integrity and safety as inherent in its Credo of living in response to global pressures.
WT Strategy
The ability to reduce internal vulnerabilities and to prevent external risks will
necessitate Johnson & Johnson to strengthen its risk management system. The WT strategies
ought to factor in reorganization endeavors towards lessening bureaucracy and improved
monitoring of the legal and regulatory environments (David et al., 2017). Moreover, there
should be crisis management and PR teams that would address the cases of public
controversy and risk on social media as quickly as possible (David et al., 2017). Internal
quality checks and adherence training will avert further product recall and regulatory fines.
These defensive strategies are necessary to eliminate doubt on the long-term confidence of
stakeholders in Johnson & Johnson and restore the position of the company as the leader in
ethical, safe, and responsible healthcare innovations.
References
David, F. R., David, F. R., & David, M. E. (2017). Strategic management: concepts and
cases: A competitive advantage approach (Vol. 127). New Jersey: Pearson.
Lehoux, P., Silva, H. P., Rocha de Oliveira, R., Sabio, R. P., & Malas, K. (2022).
Responsible innovation in health and health system sustainability: insights from
health innovators’ views and practices. Health Services Management Research, 35(4),
196-205.
Pereira, D. (2024, December 26). Johnson & Johnson Swot Analysis (2025). Business Model
Analyst. https://businessmodelanalyst.com/johnson-johnson-swot-
analysis/?srsltid=AfmBOor8GBml0pt4t4M4ZQmuPey4VbO01HTmr4KhYw-
W4q_z_pgJJR14
5
**JohnsonJohnson5YearProjection..docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/johnsonjohnson5yearprojection-docx)
– 1
– 2
– 3
– 4